Clinical characteristics and follow-up burden of false-positive newborn CAH screening results: a single-center experience

Newborn screening for congenital adrenal hyperplasia (CAH) prevents life-threatening salt-wasting crises, however, generates substantial false positives, particularly in preterm infants, due to physiological 17-hydroxyprogesterone (17-OHP) elevations. Türkiye recently expanded CAH screening nationally, yet real-world referral burden, clinical determinants of high number of false-positive referrals, and associated costs remain incompletely characterized. We aimed to describe clinical determinants of false-positive CAH screening results and quantify downstream follow-up and costs among infants referred for elevated dried blood spot 17-OHP. We retrospectively reviewed 106 infants referred to a tertiary pediatric endocrinology clinic between January 1, 2022 and July 20, 2023 for elevated NBS 17-OHP. Demographic and perinatal characteristics, hospitalization status, 17-OHP values, diagnostic outcomes, follow-up intensity, and direct healthcare costs until CAH exclusion/confirmation were collected. Non-parametric comparisons used Mann-Whitney U test; categorical variables used Fisher’s exact test ( p < 0.05). CAH was confirmed in 4/106 infants (3.8%), resulting in a PPV of 3.8%, while 102/106 (96.2%) represented false-positive referrals. Preterm birth was common (58.5%) and was associated with significantly higher 17-OHP compared with term infants ( p < 0.001). A history of hospitalization was frequent (63.2%) among referred infants. The median cost per infant until CAH exclusion was 280.5 TL (~ 11.2 USD; range 60–5000 TL [~ 2.4–200 USD]). In contrast, expenditures exceeded 15,000 TL (~ 600 USD) in one infant evaluated during severe clinical decompensation. Overall, 12.7% required > 5 outpatient visits before CAH was definitively excluded; all infants with confirmed CAH required > 5 visits. In conclusion, false-positive CAH referrals in our cohort were frequently observed in premature infants and those with a history of neonatal illness and hospitalization. These data align with international experience showing that gestational age is a major driver of false-positive CAH screens. Gestational age-adjusted first-tier 17-OHP cut-offs and standardized repeat/second-tier testing pathways may reduce unnecessary referrals and healthcare utilization while preserving timely identification of clinically significant CAH. Multicenter linkage of screening and clinical outcomes is needed to define safe population-specific thresholds in Türkiye.

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2026-11-12
DOI
https://doi.org/10.1186/s12887-026-08010-y
Primary Topic
Sexual Differentiation and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical characteristics and follow-up burden of false-positive newborn CAH screening results: a single-center experience

Derya Tepe, Mehmet Boyraz, Fatih Gürbüz, Asuman Begüm Taşbaşı et al.
BMC Pediatrics
Sexual Differentiation and Disorders
article

Clinical characteristics and follow-up burden of false-positive newborn CAH screening results: a single-center experience

Derya Tepe, Mehmet Boyraz, Fatih Gürbüz, Asuman Begüm Taşbaşı, Pınar Kocaay
article en

Abstract

Newborn screening for congenital adrenal hyperplasia (CAH) prevents life-threatening salt-wasting crises, however, generates substantial false positives, particularly in preterm infants, due to physiological 17-hydroxyprogesterone (17-OHP) elevations. Türkiye recently expanded CAH screening nationally, yet real-world referral burden, clinical determinants of high number of false-positive referrals, and associated costs remain incompletely characterized. We aimed to describe clinical determinants of false-positive CAH screening results and quantify downstream follow-up and costs among infants referred for elevated dried blood spot 17-OHP. We retrospectively reviewed 106 infants referred to a tertiary pediatric endocrinology clinic between January 1, 2022 and July 20, 2023 for elevated NBS 17-OHP. Demographic and perinatal characteristics, hospitalization status, 17-OHP values, diagnostic outcomes, follow-up intensity, and direct healthcare costs until CAH exclusion/confirmation were collected. Non-parametric comparisons used Mann-Whitney U test; categorical variables used Fisher’s exact test ( p < 0.05). CAH was confirmed in 4/106 infants (3.8%), resulting in a PPV of 3.8%, while 102/106 (96.2%) represented false-positive referrals. Preterm birth was common (58.5%) and was associated with significantly higher 17-OHP compared with term infants ( p < 0.001). A history of hospitalization was frequent (63.2%) among referred infants. The median cost per infant until CAH exclusion was 280.5 TL (~ 11.2 USD; range 60–5000 TL [~ 2.4–200 USD]). In contrast, expenditures exceeded 15,000 TL (~ 600 USD) in one infant evaluated during severe clinical decompensation. Overall, 12.7% required > 5 outpatient visits before CAH was definitively excluded; all infants with confirmed CAH required > 5 visits. In conclusion, false-positive CAH referrals in our cohort were frequently observed in premature infants and those with a history of neonatal illness and hospitalization. These data align with international experience showing that gestational age is a major driver of false-positive CAH screens. Gestational age-adjusted first-tier 17-OHP cut-offs and standardized repeat/second-tier testing pathways may reduce unnecessary referrals and healthcare utilization while preserving timely identification of clinically significant CAH. Multicenter linkage of screening and clinical outcomes is needed to define safe population-specific thresholds in Türkiye.

BMC Pediatrics
Ankara Yıldırım Beyazıt University (TR), Ankara Bilkent City Hospital (TR)
Good health and well-being
Sexual Differentiation and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon